4-65324131-C-T
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_001281766.3(EPHA5):c.3034G>A(p.Gly1012Arg) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000201 in 1,608,180 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 15/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_001281766.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
EPHA5 | NM_001281766.3 | c.3034G>A | p.Gly1012Arg | missense_variant | 17/17 | ENST00000613740.5 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
EPHA5 | ENST00000613740.5 | c.3034G>A | p.Gly1012Arg | missense_variant | 17/17 | 1 | NM_001281766.3 | A2 |
Frequencies
GnomAD3 genomes AF: 0.000152 AC: 23AN: 151422Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.000217 AC: 54AN: 249168Hom.: 0 AF XY: 0.000238 AC XY: 32AN XY: 134714
GnomAD4 exome AF: 0.000206 AC: 300AN: 1456640Hom.: 0 Cov.: 30 AF XY: 0.000210 AC XY: 152AN XY: 724704
GnomAD4 genome AF: 0.000152 AC: 23AN: 151540Hom.: 0 Cov.: 32 AF XY: 0.000122 AC XY: 9AN XY: 74062
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Jun 18, 2021 | The c.3097G>A (p.G1033R) alteration is located in exon 18 (coding exon 18) of the EPHA5 gene. This alteration results from a G to A substitution at nucleotide position 3097, causing the glycine (G) at amino acid position 1033 to be replaced by an arginine (R). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at